Relugolix
Combination
Tablet
Relugolix Combination Tablet consists of relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg. Relugolix Combination Tablet is under investigation for the prevention of pregnancy in women with uterine fibroids or endometriosis.

Relugolix Combination Tablet is not
approved by the FDA in the
prevention of pregnancy.